These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2848978)

  • 1. Extrarenal effects of aldosterone and antimineralocorticoid compounds.
    Moura AM; Angeli M; Worcel M
    Kidney Int Suppl; 1988 Oct; 26():S8-11. PubMed ID: 2848978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of RU 28318 on 22Na and 86Rb efflux from arterial smooth muscle].
    Moura AM; Worcel M
    Nephrologie; 1985; 6(3):144. PubMed ID: 4080073
    [No Abstract]   [Full Text] [Related]  

  • 3. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
    Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of aldosterone-stimulated sodium transport by steroidal spirolactones.
    Porter GA
    Mol Pharmacol; 1968 May; 4(3):224-37. PubMed ID: 5661772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Direct action of mineralocorticoid antagonists on biosynthesis of aldosterone: comparative activities of several new compounds].
    Netchitailo P; Perroteau I; Delarue C; Leboulenger F; Capron MH; Vaudry H
    Can J Physiol Pharmacol; 1983 Jan; 61(1):23-8. PubMed ID: 6301660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular and cardiac actions of aldosterone and spironolactone.
    Zannad F
    Z Kardiol; 1991; 80 Suppl 7():103-5. PubMed ID: 1792814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial effects of aldosterone and antimineralocorticoid compounds mechanism of action.
    Worcel M; Moura AM
    J Steroid Biochem; 1987; 27(4-6):865-9. PubMed ID: 3320564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular action of aldosterone].
    Miyamori I; Kawai Y; Fan CY
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():40-5. PubMed ID: 16895168
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 45-year story of the development of an anti-aldosterone more specific than spironolactone.
    Ménard J
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):45-52. PubMed ID: 15134800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
    de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
    J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal effects of aldosterone and spironolactone in rats f different age].
    Bräunlich H; Kersten L
    Acta Biol Med Ger; 1972; 28(1):73-80. PubMed ID: 5048187
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
    Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
    Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action mechanism and metabolism of 17-spirolactones in the body].
    Miyazaki T
    Nihon Rinsho; 1982; 40(3):652-9. PubMed ID: 7098029
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of drospirenone on cardiovascular markers in human aortic endothelial cells.
    Seeger H; Wallwiener D; Mueck AO
    Climacteric; 2009 Feb; 12(1):80-7. PubMed ID: 18979300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide.
    Balfagón G; Márquez-Rodas I; Alvarez Y; Alonso MJ; Cachofeiro V; Salaices M; Lahera V
    Regul Pept; 2004 Aug; 120(1-3):253-60. PubMed ID: 15177944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
    Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
    Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct action of aldosterone on transmembrane 22Na efflux from arterial smooth muscle. Rapid and delayed effects.
    Moura AM; Worcel M
    Hypertension; 1984; 6(3):425-30. PubMed ID: 6329952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.